India needs to update its rules for biosimilars to ensure safe, effective, and affordable medicines

India needs to update its rules for biosimilars to ensure safe, effective, and affordable medicines

Strengthening India’s biosimilar guidelines needs evidence-based regulatory modernisation Strengthening India’s biosimilar guidelines needs evidence-based regulatory modernisation Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu

Leave a Reply

Your email address will not be published. Required fields are marked *